Nanoparticles for hyperthermic therapy: Synthesis strategies and applications in glioblastoma

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2863-2877

  Verma, Jyoti ^a,b   Lal, Sumit ^a   Van Noorden, Cornelis J F ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Carbon nanotubes; Gold nanorods; Hyperthermia; SPIONs; Targeted drug delivery

Indexed keywords

CARBON; CARBON NANOTUBE; DOXORUBICIN; GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; METAL; MULTI WALLED NANOTUBE; NANOPARTICLE; NANOROD; POLYMER; SILICON DIOXIDE; SINGLE WALLED NANOTUBE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; SURFACTANT;

ABLATION THERAPY; CHEMICAL MODIFICATION; DECOMPOSITION; DRUG DELIVERY SYSTEM; ELECTROCHEMICAL ANALYSIS; GLIOBLASTOMA; HUMAN; HYPERTHERMIC THERAPY; IN VITRO STUDY; IN VIVO STUDY; MATERIAL COATING; MICROEMULSION; NONHUMAN; OXIDATION; PRECIPITATION; REVIEW; SYNTHESIS; ANIMAL; BRAIN NEOPLASMS; CHEMISTRY; PROCEDURES; ULTRASTRUCTURE;

ANIMALS; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; HYPERTHERMIA, INDUCED; NANOPARTICLES;

EID: 84902387944     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S57501     Document Type: Review

References (109)

1. Brandes AA, Tosoni A, Franceschi E, Reni M, Gatta G, Vecht C. Glioblastoma in adults. Crit Rev Oncol Hematol. 2008;67(2):139-152.
2. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492-507.
3. Iacob G, Dinca EB. Current data and strategy in glioblastoma multiforme. J Med Life. 2009;2(4):386-393.
4. Piroth MD, Gagel B, Pinkawa M, Stanzel S, Asadpour B, Eble MJ. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors. Strahlenther Onkol. 2007;183(12):695-702.
5. Stupp R, Mason W P, van den Bent MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Eng J Med. 2005;352(10):987-996.
6. Moustakas A, Kreisl TN. New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab. Onco Targets Ther. 2010;3:27-38.
7. Stupp R, Hegi ME, Mason W P, et al; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temo-zolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-466.
8. Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol. 2002;43(1):33-56.
9. Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002;3(8):487-497.
10. Jordan A. Thermotherapy and nanomedicine: between vision and reality. In: Baronzio GF, Hager ED, editors. Hyperthermia in Cancer Treatment: A Primer. 3rd ed. New York, NY: Springer; 2006:60-63.
11. Elliott DG, Haskins GM, Rand RW, Snow HD; inventors. Induction heating method for use in causing necrosis of neoplasm. United States Patent US4545368 A. October 8, 1985.
12. Gilchrist RK, Medal R, Shorey WD, Hanselman RC, Parrott JC, Taylor CB. Selective inductive heating of lymph nodes. Ann Surg. 1957;146(4):596-606.
13. Ito A, Shinkai M, Honda H, Kobayashi T. Medical application of func-tionalized magnetic nanoparticles. J Biosci Bioeng. 2005;100(1):1-11.
14. Mornet S, Vasseur S, Grasset F, et al. Magnetic nanoparticle design for medical applications. Prog Solid State Chem. 2006;34(2-4):237-247.
15. Faraji M, Yamini Y, Rezaee M. Magnetic nanoparticles: synthesis, stabilization, functionalization, characterization, and applications. J Iran Chem Soc. 2010;7(1):1-37.
16. Petri-Fink A, Hofmann H. Superparamagnetic iron oxide nanopar-ticles (SPIONs): from synthesis to in vivo studies - a summary of the synthesis, characterization, in vitro, and in vivo investigations of SPIONs with particular focus on surface and colloidal properties. IEEE Trans Nanobioscience. 2007;6(4):289-297.
17. Editors of Encyclopaedia Britannica. Curie point [webpage on the Internet]. Encyclopaedia Britannica. Available from: http://www.britannica.com/EBchecked/topic/146902/Curie-point. Accessed October 14, 2013.
18. Martirosyan KS. Thermosensitive magnetic nanoparticles for self-controlled hyperthermia cancer treatment. J Nanomed Nanotechnol. 2012;3(6):1-2.
19. Jordan A, Scholz R, Maier-Hauff K, et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol. 2006;78(1):7-14.
20. Lu AH, Salabas EL, Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl. 2007;46(8):1222-1244.
21. Wu W, He Q, Jiang C. Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res Lett. 2008;3(11): 397-415.
22. Suh SK, Yuet K, Hwang DK, Bong K W, Doyle PS, Hatton TA. Synthesis of nonspherical superparamagnetic particles: in situ copre-cipitation of magnetic nanoparticles in microgels prepared by stop-fow lithography. J Am Chem Soc. 2012;134(17):7337-7343.
23. Perez De Berti IO, Cagnoli M V, Pecchi G, et al. Alternative low-cost approach to the synthesis of magnetic iron oxide nanoparticles by thermal decomposition of organic precursors. Nanotechnology. 2013; 24(17):175601.
24. Sun S, Zeng H. Size-controlled synthesis of magnetite nanoparticles. J Am Chem Soc. 2002;124(28):8204-8205.
25. Hyeon T, Lee SS, Park J, Chung Y, Na HB. Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chem Soc. 2001;123(51):12798-12801.
26. Park J, An K, Hwang Y, et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater. 2004;3(12):891-895.
27. Inouye K, Endo R, Otsuka Y, Miyashiro K, Kaneko K, Ishikawa T. Oxygenation of ferrous ions in reversed micelle and reversed microemulsion. J Phys Chem. 1982;86(8):1465-1469.
28. Lee Y, Lee J, Bae CJ, et al. Large-scale synthesis of uniform and crystalline magnetite nanoparticles using reverse micelles as nanoreactors under refux conditions. Adv Functional Mat. 2005;15(3):503-509.
29. Peng DL, Sumiyama K, Hihara T, Yamamuro S, Konno TJ. Magnetic properties of monodispersed Co/CoO clusters. Phys Rev B. 2000;61(4): 3103-3109.
30. Bönnemann H, Brijoux W, Brinkmann R, et al. A size-selective synthesis of air stable colloidal magnetic cobalt nanoparticles. Inorganica Chimica Acta. 2003;350:617-624.
31. Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. Magn IEEE Trans. 1981;17(2):1247-1248.
32. Shen L, Laibinis PE, Hatton TA. Bilayer surfactant stabilized magnetic fuids: synthesis and interactions at interfaces. Langmuir. 1999; 15(2):447-453.
33. Sousa MH, Tourinho FA. New electric double-layered magnetic fuids based on copper, nickel, and zinc ferrite nanostructures. J Phys Chem B. 2001;105(6):1168-1175.
34. Wan M, Li J. Synthesis and electrical-magnetic properties of polyaniline composites. J Polym Sci A. 2003;36(15):2799-2805.
35. Butterworth MD, Bell SA, Armes S P, Simpson AW. Synthesis and characterization of polypyrrole-magnetite-silica particles. J Colloid Interf Sci. 1996;183(1):91-99.
36. Asti G, Solzi M, Ghidini M. Infuence of domain walls on the singular point detection of energy losses in hard magnetic materials. J Magn Magn Mater. 2005;290-291(Pt 1):533-535.
37. Barratt G. Colloidal drug carriers: achievements and perspectives. Cell Mol Life Sci. 2003;60(1):21-37.
38. Cho SJ, Idrobo JC, Olamit J, Liu K, Browning ND, Kauzlarich SM. Growth mechanisms and oxidation-resistance of gold-coated iron nanoparticles. Chem Mater. 2005;17(12):3181-3186.
39. Caruntu D, Cushing BL, Caruntu G, O'Connor CJ. Attachment of gold nanograins onto colloidal magnetite nanocrystals. Chem Mater. 2005;17(13):3398-3402.
40. Ban Z, Barnakov YA, Li F, Golub VO, O'Connor CJ. The synthesis of core-shell iron@gold nanoparticles and their characterization. J Mater Chem. 2005;15:4660-4662.
41. Liu Q, Xu Z, Finch JA, Egerton R. A novel two-step silica-coating process for engineering magnetic nanocomposites. Chem Mater. 1998;10(12):3936-3940.
42. Zhang J, Post M, Veres T, et al. Laser-assisted synthesis of superparamagnetic Fe@Au core-shell nanoparticles. J Phys Chem B. 2006;110(14):7122-7128.
43. Chen H, Shao L, Li Q, Wang J. Gold nanorods and their plasmonic properties. Chem Soc Rev. 2013;42:2679-2724.
44. Young JK, Figueroa ER, Drezek RA. Tunable nanostructures as photo-thermal theranostic agents. Ann Biomed Eng. 2012;40(2):438-459.
45. Vigderman L, Khanal B P, Zubarev R. Functional gold nanorods: synthesis, self-assembly, and sensing applications. Adv Mater. 2012;24(36):4811-4841.
46. Genzel L, Martin T P, Kreibig U. Dielectric function and plasma resonances of small metal particles. Z Physik B. 1975;21(4): 339-346.
47. Nikoobakht B, Wang ZL, El-Sayed MA. Self-Assembly of gold nanorods. J Phys Chem B. 2000;104(36):8635-8640.
48. Kim JY, Ah CS, Jang DJ. Controlled aspect ratios of gold nanorods in reduction-limited conditions. J Nanomater. 2011;405853:1-7.
49. Brown KR, Walter DG, Natan MJ. Seeding of colloidal Au nanoparticle solutions. 2. Improved control of particle size and shape. Chem Mater. 2000;12(2):306-313.
50. Jana NR, Gearheart L, Murphy CJ. Seed mediated growth approach for shape-controlled synthesis of spheroidal and rod-like gold nanoparticles using a surfactant template. Adv Mater. 2001;13(18):1389-1393.
51. Jana NR, Gearheart L, Murphy CJ. Wet chemical synthesis of high aspect ratio gold nanorods. J Phys Chem B. 2001;105(19):4065-4067.
52. Hu M, Hillyard P, Hartland G V, Kosel T, Perez-Juste J, Mulvaney P. Determination of the elastic constants of gold nanorods produced by seed-mediated growth. Nano Lett. 2004;4(12):2493-2497.
53. Wu W, Huang J, Wu L, et al. Two-step size- and shape- separation of biosynthesized gold nanoparticles. Sep Purif Technol. 2013;106: 117-122.
54. Wei GT, Liu FK, Wang CRC. Shape separation of nanometer gold particles by size exclusion chromatography. Anal Chem. 1999;71(11): 2085-2091.
55. Jana NR. Nanorod shape separation using surfactant assisted self-assembly. Chem Commun. 2003;15:1950-1951.
56. Sharma V, Park K, Srinivasarao M. Shape separation of gold nano-rods using centrifugation. Proc Natl Acad Sci U S A. 2009;106(13): 4981-4985.
57. Mitamura K, Imae T. Functionalization of gold nanorods toward their applications. Plasmonics. 2009;4:23-30.
58. Mitamura K, Imae T, Saito N, Takai O. Fabrication and structure of alginate gel incorporating gold nanorods. J Phys Chem C. 2008;112(2): 416-422.
59. Gorelikov I, Field LM, Kumacheva E. Hybrid microgels photoresponsive in the near-infrared spectral range. J Am Chem Soc. 2004;126(49): 15938-15939.
60. Kumar VRR, Samal AK, Sreeprasad TS, Pradeep T. Gold nanorods grown on microgels leading to hexagonal nanostructures. Langmuir. 2007;23(17):8667-8669.
61. Gentili D, Ori G, Franchini MC. Double phase transfer of gold nanorods for surface functionalization and entrapment into PEG-based nanocarriers. Chem Commun. 2009;39:5874-5876.
62. Khanal B P, Rings of nanorods. Angew Chem Int Edit. 2007;46(13):2195-2198.
63. Radushkevich LV, Lukyanovich VM. About structure of carbon created at thermal decomposition of carbon monoxide on iron contact. J Phys Chem. 1952;26:88-95.
64. Iijima S. Helical microtubules of graphitic carbon. Nature. 1991;354: 56-58.
65. Kumar M, Ando Y. Chemical vapor deposition of carbon nanotubes: a review on growth mechanism and mass production. J Nanosci Nanotechnol. 2010;10(6):3739-3758.
66. Wang M, Zhao X, Ohkohchi M, Ando Y. Carbon nanotubes grown on the surface of cathode deposit by arc discharge. Fullerene Sci Technol. 1996;4(5):1027-1039.
67. Zhao XL, Wang M, Ohkohchi M, Ando Y. Morphology of carbon nanotubes prepared by carbon arc. Jpn J Appl Phys. 1996;35(Pt 1): 4451-4456.
68. Parkansky N, Boxman RL, Alterkop B, Zontag I, Lereah Y, Barkay Z. Single-pulse arc production of carbon nanotubes in ambient air. J Phys D Appl Phys. 2004;37(19):2715-2719.
69. Sornsuwit N, Maaithong W. Study of multi-walled carbon nanotubes synthesis using liquid nitrogen and the purifcation. Poster presented at: Asian Symposium for Precision Engineering and Nanotechnology; November 6-9, 2007; Gwangju, South Korea.
70. Montoro LA, Lofrano RCZ, Rosolen JM. Synthesis of single-walled and multi-walled carbon nanotubes by arc-water method. Carbon. 2005;43:200-203.
71. Jung SH, Kim MR, Jeong SH, et al. High-yield synthesis of multi-walled carbon nanotubes by arc discharge in liquid nitrogen. Appl Phys A. 2003;76(2):285-286.
72. Iijima S, Ichihashi T. Single-shell carbon nanotubes of 1-nm diameter. Nature. 1993;363:603-605.
73. Bethune DS, Kiang CH, De Vries MS, et al. Cobalt-catalysed growth of carbon nanotubes with single-atomic-layer walls. Nature. 1993;363:605-607.
74. Chen B, Zhao X, Inoue S, Ando Y. Fabrication and dispersion evaluation of single-wall carbon nanotubes produced by FH-arc discharge method. J Nanosci Nanotechnol. 2010;10(6):3973-3977.
75. Fan W W, Lu YK, Bao WR, Zhao J, Fan BY. Preparation of coal-based carbon nanotube with FeS-Co2O3 as catalyst. J Mat Eng. 2008;10: 363-365.
76. Moshkalyov SA, Moreau ALD, Guttiérrez HR, Cotta MA, Swart J W. Carbon nanotubes growth by chemical vapor deposition using thin flm nickel catalyst. Mater Sci Eng B. 2004;112:147-153.
77. Dikonimos Makris TH, Giorgi L, Giorgi R, et al. CVD synthesis of carbon nanotubes on different substrates. Nato Sci Ser II Math. 2006; 222:59-60.
78. Ren ZF, Huang Z W, Xu J W, et al. Synthesis of large arrays of well-aligned carbon nanotubes on glass. Science. 1998;282(5391):1105-1107.
79. Fan S, Chapline MG, Franklin NR, Tombler T W, Cassell AM, Dai HJ. Self-oriented regular arrays of carbon nanotubes and their feld emission properties. Science. 1999;283(5401):512-514.
80. Nessim GD. Properties, synthesis, and growth mechanisms of carbon nanotubes with special focus on thermal chemical vapor deposition. Nanoscale. 2010;2:1306-1323.
81. Shinkai M, Yanase M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic lipo-somes: in vitro study. Jpn J Cancer Res. 1996;87(11):1179-1183.
82. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study. Jpn J Cancer Res. 1997;88(7):630-632.
83. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. Jpn J Cancer Res. 1998;89(4):463-469.
84. Ito A, Shinkai M, Honda H, et al. Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunol Immunother. 2003; 52(2):80-88.
85. Ito A, Honda H, Kobayashi T. Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression. Cancer Immunol Immunother. 2006;55(3):320-328.
86. Le B, Shinkai M, Kitade T, et al. Preparation of tumor-specific magnetoliposomes and their application for hyperthermia. J Chem Eng Jpn. 2001;34(1):66-72.
87. http://www.nanostart.de/en/news/press-releases/portfolio/archive/2011/873-nanostart-holding-magforce-reimbursement-of-nanotherm-therapy.
88. Kost J, Noecker R, Kunica E, Langer R. Magnetically controlled release systems: effect of polymer composition. J Biomed Mater Res. 1985;19(8):935-940.
89. Edelman ER, Kost J, Bobeck H, Langer R. Regulation of drug release from polymer matrices by oscillating magnetic felds. J Biomed Mater Res. 1985;19(1):67-83.
90. Kumar CS, Mohammad F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv Drug Deliv Rev. 2011;63(9):789-808.
91. Brazel CS. Magnetothermally-responsive nanomaterials: combining magnetic nanostructures and thermally-sensitive polymers for triggered drug release. Pharm Res. 2009;26(3):644-656.
92. Hoare T, Santamaria J, Goya GF, et al. A magnetically triggered composite membrane for on-demand drug delivery. Nano Lett. 2009;9(10): 3651-3657.
93. Behrens S, Bönnemann H, Matoussevitch N, et al. Air-stable Co-, Fe-, and Fe/Co-nanoparticles and ferrofluids. Phys Chem. 2006; 220(1):3-40.
94. Atai NA, Balaj L, Van Veen H, et al. Heparin blocks transfer of extracellular vesicles between donor and recipient cells. J Neurooncol. 2013;115:343-351.
95. Lu Z, Prouty MD, Guo Z, Golub VO, Kumar CS, Lvov YM. Magnetic switch of permeability for polyelectrolyte microcapsules embedded with Co@Au nanoparticles. Langmuir. 2005;21(5):2042-2050.
96. Zhang H, Pan D, Zou K, He J, Duan X. A novel core-shell structured magnetic organic-inorganic nanohybrid involving drug-intercalated layered double hydroxides coated on a magnesium ferrite core for magnetically controlled drug release. J Mater Chem. 2009;19:3069-3077.
97. Jain PK, El-Sayed IH, El-Sayed MA. Au nanoparticles target cancer. Nano Today. 2007;2(1):18-29.
98. Mehdizadeh A, Pandesh S, Shakeri-Zadeh, et al. The effects of folate-conjugated gold nanorods in combination with plasmonic photothermal therapy on mouth epidermal carcinoma cells. Lasers Med Sci. Epub September 7, 2013.
99. Choi J, Yang J, Park J, et al. Specifc near-IR absorption imaging of glioblastomas using integrin-targeting gold nanorods. Adv Funct Mater. 2011;21(6):1082-1088.
100. Fernandez Cabada T, de Pablo CS, Serrano AM, Guerrero Fdel P, Olmedo JJ, Gomez MR. Induction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods. Intl J Nanomedicine. 2012;7:1511-1523.
101. Oli M. Aptamer conjugated gold nanorods for targeted nanothermal radiation of glioblastoma cancer cells. Young Sci J. 2010;3(8): 18-25.
102. Agarwal A, Mackey MA, El-Sayed MA, Bellamkonda RV. Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano. 2011;5(6): 4919-4926.
103. Xiao Y, Hong H, Matson VZ, et al. Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging. Theranostics. 2012;2(8):757-768.
104. Zhang Z, Wang L, Wang J, et al. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mater. 2012;24(11):1418-1423.
105. Fabbro C, Ali-Boucetta H, Da Ros T, Kostarelos K, Bianco A, Prato M. Targeting carbon nanotubes against cancer. Chem Commun. 2012;48(33):3911-3926.
106. Markovic ZM, Harhaji-Trajkovic LM, Todorovic-Markovic BM, et al. In vitro comparison of the photothermal anticancer activity of gra-phene nanoparticles and carbon nanotubes. Biomaterials. 2011;32(4): 1121-1129.
107. Wang CH, Chiou SH, Chou CP, Chen YC, Huang YJ, Peng CA. Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody. Nanomedicine. 2011;7(1):69-79.
108. Wang CH, Huang YJ, Chang CW, Hsu WM, Peng CA. In vitro pho-tothermal destruction of neuroblastoma cells using carbon nanotubes conjugated with GD2 monoclonal antibody. Nanotechnology. 2009;20(31):315101.
109. Zonghuan L, Malcolm PD, Zhanhu G, et al. Magnestic switch of permeability for polyelectrolyte microcapsules embedded with nano-particles. Langmuir. 2005;21:2042-2050.